nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.0311	0.0326	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.0311	0.0326	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.0293	0.0308	CcSEcCtD
Nalidixic Acid—Trauma—Formoterol—chronic obstructive pulmonary disease	0.0258	0.0271	CcSEcCtD
Nalidixic Acid—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.0258	0.0271	CcSEcCtD
Nalidixic Acid—Trauma—Montelukast—chronic obstructive pulmonary disease	0.0252	0.0265	CcSEcCtD
Nalidixic Acid—Papilloedema—Prednisolone—chronic obstructive pulmonary disease	0.0209	0.0219	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.0159	0.0167	CcSEcCtD
Nalidixic Acid—Papilloedema—Prednisone—chronic obstructive pulmonary disease	0.0152	0.0159	CcSEcCtD
Nalidixic Acid—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.014	0.0147	CcSEcCtD
Nalidixic Acid—Epilepsy—Prednisone—chronic obstructive pulmonary disease	0.0127	0.0133	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.0121	0.0127	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0121	CcSEcCtD
Nalidixic Acid—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.011	0.274	CrCbGaD
Nalidixic Acid—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.0108	0.0113	CcSEcCtD
Nalidixic Acid—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.0103	0.257	CrCbGaD
Nalidixic Acid—Trauma—Prednisone—chronic obstructive pulmonary disease	0.0101	0.0106	CcSEcCtD
Nalidixic Acid—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00969	0.0102	CcSEcCtD
Nalidixic Acid—Injury—Formoterol—chronic obstructive pulmonary disease	0.00969	0.0102	CcSEcCtD
Nalidixic Acid—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00966	0.0101	CcSEcCtD
Nalidixic Acid—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0095	0.00997	CcSEcCtD
Nalidixic Acid—Injury—Montelukast—chronic obstructive pulmonary disease	0.00949	0.00997	CcSEcCtD
Nalidixic Acid—Blister—Prednisolone—chronic obstructive pulmonary disease	0.00922	0.00968	CcSEcCtD
Nalidixic Acid—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00915	0.00961	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00786	0.00825	CcSEcCtD
Nalidixic Acid—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.00785	0.00824	CcSEcCtD
Nalidixic Acid—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00781	0.194	CrCbGaD
Nalidixic Acid—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00747	0.00784	CcSEcCtD
Nalidixic Acid—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00736	0.00773	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00705	0.00741	CcSEcCtD
Nalidixic Acid—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00685	0.00719	CcSEcCtD
Nalidixic Acid—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00682	0.00716	CcSEcCtD
Nalidixic Acid—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00672	0.00706	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00667	0.007	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00659	0.00692	CcSEcCtD
Nalidixic Acid—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00648	0.0068	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00635	0.00667	CcSEcCtD
Nalidixic Acid—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00619	0.0065	CcSEcCtD
Nalidixic Acid—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00611	0.00641	CcSEcCtD
Nalidixic Acid—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00607	0.00638	CcSEcCtD
Nalidixic Acid—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00594	0.00623	CcSEcCtD
Nalidixic Acid—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00594	0.00623	CcSEcCtD
Nalidixic Acid—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0059	0.0062	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00575	0.00604	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00571	0.00599	CcSEcCtD
Nalidixic Acid—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00571	0.00599	CcSEcCtD
Nalidixic Acid—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00566	0.00594	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.00561	0.14	CrCbGaD
Nalidixic Acid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00549	0.00576	CcSEcCtD
Nalidixic Acid—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00544	0.00571	CcSEcCtD
Nalidixic Acid—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00543	0.0057	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00541	0.135	CrCbGaD
Nalidixic Acid—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0054	0.00567	CcSEcCtD
Nalidixic Acid—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00525	0.00551	CcSEcCtD
Nalidixic Acid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00512	0.00538	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00505	0.0053	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00499	0.00523	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00494	0.00519	CcSEcCtD
Nalidixic Acid—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0049	0.00515	CcSEcCtD
Nalidixic Acid—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0049	0.00515	CcSEcCtD
Nalidixic Acid—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00487	0.00511	CcSEcCtD
Nalidixic Acid—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.0048	0.00504	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0047	0.00494	CcSEcCtD
Nalidixic Acid—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00463	0.00486	CcSEcCtD
Nalidixic Acid—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00457	0.0048	CcSEcCtD
Nalidixic Acid—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00457	0.00479	CcSEcCtD
Nalidixic Acid—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00457	0.00479	CcSEcCtD
Nalidixic Acid—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00455	0.00478	CcSEcCtD
Nalidixic Acid—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00455	0.00478	CcSEcCtD
Nalidixic Acid—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00455	0.00477	CcSEcCtD
Nalidixic Acid—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00447	0.0047	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00444	0.00466	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00438	0.0046	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00438	0.0046	CcSEcCtD
Nalidixic Acid—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00431	0.00453	CcSEcCtD
Nalidixic Acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00431	0.00452	CcSEcCtD
Nalidixic Acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00429	0.0045	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00429	0.0045	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0042	0.00441	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00413	0.00434	CcSEcCtD
Nalidixic Acid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00407	0.00427	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00399	0.00419	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00399	0.00419	CcSEcCtD
Nalidixic Acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00394	0.00413	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00391	0.0041	CcSEcCtD
Nalidixic Acid—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00389	0.00409	CcSEcCtD
Nalidixic Acid—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00389	0.00409	CcSEcCtD
Nalidixic Acid—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00385	0.00404	CcSEcCtD
Nalidixic Acid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00384	0.00403	CcSEcCtD
Nalidixic Acid—Injury—Prednisone—chronic obstructive pulmonary disease	0.00381	0.004	CcSEcCtD
Nalidixic Acid—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00381	0.004	CcSEcCtD
Nalidixic Acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0038	0.00399	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.00395	CcSEcCtD
Nalidixic Acid—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00371	0.0039	CcSEcCtD
Nalidixic Acid—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00368	0.00386	CcSEcCtD
Nalidixic Acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00366	0.00384	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00364	0.00383	CcSEcCtD
Nalidixic Acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00363	0.00381	CcSEcCtD
Nalidixic Acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00362	0.0038	CcSEcCtD
Nalidixic Acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0036	0.00378	CcSEcCtD
Nalidixic Acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00359	0.00377	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00358	0.00376	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00358	0.00376	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00351	0.00368	CcSEcCtD
Nalidixic Acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00348	0.00365	CcSEcCtD
Nalidixic Acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00348	0.00365	CcSEcCtD
Nalidixic Acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00346	0.00363	CcSEcCtD
Nalidixic Acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00346	0.00363	CcSEcCtD
Nalidixic Acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00345	0.00362	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00342	0.00359	CcSEcCtD
Nalidixic Acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00359	CcSEcCtD
Nalidixic Acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00359	CcSEcCtD
Nalidixic Acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00342	0.00359	CcSEcCtD
Nalidixic Acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00341	0.00358	CcSEcCtD
Nalidixic Acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0034	0.00357	CcSEcCtD
Nalidixic Acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00339	0.00356	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00338	0.00355	CcSEcCtD
Nalidixic Acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00328	0.00345	CcSEcCtD
Nalidixic Acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00327	0.00343	CcSEcCtD
Nalidixic Acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00322	0.00338	CcSEcCtD
Nalidixic Acid—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00322	0.00338	CcSEcCtD
Nalidixic Acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00314	0.0033	CcSEcCtD
Nalidixic Acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00314	0.0033	CcSEcCtD
Nalidixic Acid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0031	0.00325	CcSEcCtD
Nalidixic Acid—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0031	0.00325	CcSEcCtD
Nalidixic Acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00308	0.00323	CcSEcCtD
Nalidixic Acid—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00303	0.00319	CcSEcCtD
Nalidixic Acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.003	0.00314	CcSEcCtD
Nalidixic Acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.003	0.00314	CcSEcCtD
Nalidixic Acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00297	0.00311	CcSEcCtD
Nalidixic Acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00293	0.00308	CcSEcCtD
Nalidixic Acid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00307	CcSEcCtD
Nalidixic Acid—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00291	0.00305	CcSEcCtD
Nalidixic Acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00304	CcSEcCtD
Nalidixic Acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00304	CcSEcCtD
Nalidixic Acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00298	CcSEcCtD
Nalidixic Acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.00297	CcSEcCtD
Nalidixic Acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00278	0.00292	CcSEcCtD
Nalidixic Acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00278	0.00292	CcSEcCtD
Nalidixic Acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.0029	CcSEcCtD
Nalidixic Acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.00276	0.0029	CcSEcCtD
Nalidixic Acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.0029	CcSEcCtD
Nalidixic Acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00276	0.0029	CcSEcCtD
Nalidixic Acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.00274	0.00288	CcSEcCtD
Nalidixic Acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00274	0.00288	CcSEcCtD
Nalidixic Acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00287	CcSEcCtD
Nalidixic Acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00273	0.00286	CcSEcCtD
Nalidixic Acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.0027	0.00284	CcSEcCtD
Nalidixic Acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0027	0.00284	CcSEcCtD
Nalidixic Acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.00269	0.00282	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.00279	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00265	0.00278	CcSEcCtD
Nalidixic Acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00276	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00261	0.00274	CcSEcCtD
Nalidixic Acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00274	CcSEcCtD
Nalidixic Acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00273	CcSEcCtD
Nalidixic Acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0026	0.00273	CcSEcCtD
Nalidixic Acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0026	0.00273	CcSEcCtD
Nalidixic Acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00272	CcSEcCtD
Nalidixic Acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00267	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00252	0.00264	CcSEcCtD
Nalidixic Acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00258	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00237	0.00249	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00213	0.00224	CcSEcCtD
Nalidixic Acid—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00211	0.00222	CcSEcCtD
Nalidixic Acid—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00193	0.00203	CcSEcCtD
Nalidixic Acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.0019	0.00199	CcSEcCtD
Nalidixic Acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00188	0.00198	CcSEcCtD
Nalidixic Acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00192	CcSEcCtD
Nalidixic Acid—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00189	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00172	0.00181	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00165	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00165	CcSEcCtD
Nalidixic Acid—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00162	CcSEcCtD
Nalidixic Acid—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.00157	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00157	CcSEcCtD
Nalidixic Acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00156	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00148	CcSEcCtD
Nalidixic Acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.00148	CcSEcCtD
Nalidixic Acid—TDO2—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00138	0.191	CbGpPWpGaD
Nalidixic Acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00144	CcSEcCtD
Nalidixic Acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00143	CcSEcCtD
Nalidixic Acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00124	0.0013	CcSEcCtD
Nalidixic Acid—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00128	CcSEcCtD
Nalidixic Acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00124	CcSEcCtD
Nalidixic Acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00114	0.0012	CcSEcCtD
Nalidixic Acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00115	CcSEcCtD
Nalidixic Acid—Rash—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00114	CcSEcCtD
Nalidixic Acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00114	CcSEcCtD
Nalidixic Acid—Headache—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00113	CcSEcCtD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—APIP—chronic obstructive pulmonary disease	0.00103	0.143	CbGpPWpGaD
Nalidixic Acid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00107	CcSEcCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00093	0.129	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000676	0.0939	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000618	0.0858	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.0005	0.0695	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000363	0.0504	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—GCLC—chronic obstructive pulmonary disease	0.000359	0.0498	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000189	0.0263	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000132	0.0183	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000125	0.0174	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GC—chronic obstructive pulmonary disease	0.000122	0.0169	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000117	0.0163	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000113	0.0158	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.66e-05	0.00926	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.59e-05	0.00915	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.01e-05	0.00835	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.54e-05	0.0077	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.62e-05	0.00642	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.56e-05	0.00633	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.24e-05	0.0059	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.00559	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.05e-05	0.00424	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALB—chronic obstructive pulmonary disease	2.74e-05	0.0038	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.62e-05	0.00364	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.58e-05	0.00359	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.55e-05	0.00216	CbGpPWpGaD
